Skip to main content
. 2010 Jul 1;285(38):29569–29576. doi: 10.1074/jbc.M110.127639

FIGURE 2.

FIGURE 2.

Characterization of the purified LRRK2 phospho-specific antibodies using specific peptides. A, ELISA using antibody anti-pT2031 and phospho-LRRK2 peptide (pT2031) and nonphosphorylated peptide control. B, ELISA using antibody anti-pS2032 and phospho-LRRK2 peptide (pS2032) and nonphosphorylated peptide control. C, ELISA using antibody anti-pT2035 and phospho-LRRK2 peptide (pT2035) and nonphosphorylated peptide control. D, dot blot using specific phospho- and its corresponding nonphosphoantibody.